GDC-0068

· Genentech, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for GDC-0068, covering 2016-03-28 to 2016-07-04. Get the full timeline:

Most recent: Clinical Trial Update: A Study Evaluating the Safety and Tolerability of GDC-0068 in Patients With Refractory Solid Tumors [Phase 1]